Biotech news on June 15, 2026

1. 0123:30 UTC

   Former drug strategist pens book on opioid crisis

   3 outlets · first: thesudburystar.com Pharma

   Machine summary A former drug strategist has written a book on the opioid crisis, according to reports.

   Reported by thesudburystar.com, saultstar.com and elliotlakestandard.ca.

2. 0210:15 UTC

   Coverage recordwinnipegfreepress.com: “Congo reports record one - day increase in Ebola cases, a month after outbreak declaration”

   2 outlets · first: Winnipeg Free Press Clinical trial

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by Winnipeg Free Press and WRAL.

3. 0313:13 UTC

   Novo Nordisk discloses IT security incident involving unauthorised access

   2 outlets · first: unsafe.sh Clinical trial

   Machine summary The incident affected clinical trial patients and healthcare providers.

   Reported by unsafe.sh and securityaffairs.com.

   • Novo Nordisk

   Full coverage: every report, when each was published, and who was named (2 outlets)

4. 0422:15 UTC

   Wisconsin beagle facility closing; rescue group takes dogs

   2 outlets · first: chicoer.com Pharma

   Reported by chicoer.com and Boston Herald.

5. 0518:30 UTC

   DaVita, Encompass Health, Ocular Therapeutix and Prime Medicine compared

   1 outlet · first: fool.com

   Machine summary Two reports compare healthcare stocks: DaVita and Encompass Health, and Ocular Therapeutix and Prime Medicine. The reports present financial figures and business descriptions for each company.

   1. DaVita operates 3,242 outpatient centers and reported FY 2025 revenue of nearly $13.6 billion, up approximately 6.5%, with net income of roughly $746.8 million, according to the report.
   2. Encompass Health operated 173 inpatient rehabilitation hospitals across 39 states and Puerto Rico as of the end of 2025, the report said.
   3. Ocular Therapeutix generated approximately $51.8 million in FY 2025 revenue, a decrease of nearly 18.7%, and reported a net loss of close to $265.9 million, according to the report.

   Reported by fool.com.

   • DaVita
   • Ocular Therapeutix
   • Encompass Health
   • Prime Medicine

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.